ADDF’s grant to Abiant for developing accurate imaging diagnostic approach The Alzheimer’s Drug Discovery Foundation announced today that it is providing a grant of $200,000 to Abiant, Inc. , for the development of an extremely accurate imaging diagnostic for Alzheimer’s Disease. Abiant, a privately held company, is dedicated to the use of neuroimaging to improve the treatment and diagnosis of neurologic and neuropsychiatric disorders. Abiant’s diagnostic approach combines key developments in the analysis of Positron Emission Tomography images of the mind. The to begin these was developed by Lisa Mosconi, PhD, Henry Rusinek, PhD, and Wai Tsui, PhD at the NYU School of Medicine’s Center for Brain Health, directed by Mony de Leon, PhD.A 2006 JAMA study estimates that 60 % of U nearly.S. Women and men between the age range of 14 and 49 carry the HSV-1 virus. The CDC estimates that about 1 in 6 People in america between 14 and 49 are infected with herpes virus type 2 , according to a 2010 nationwide health survey. HSV-2 is definitely a lifelong and incurable an infection that may cause recurrent and painful genital sores and may make those contaminated with the virus two-to-three times much more likely to obtain HIV, the virus that causes Helps. Dr. Herold and her colleagues had previously proven that illness by the herpes viruses depends upon calcium released within the cells.